168 related articles for article (PubMed ID: 17066854)
1. Off-label marketing stirs a legal hornet's nest.
Guglielmo WJ
Med Econ; 2006 Oct; 83(19):47-9. PubMed ID: 17066854
[No Abstract] [Full Text] [Related]
2. Physicians' liability for off-label prescriptions.
Riley JB; Basilius PA
Nephrol News Issues; 2007 Jun; 21(7):43-4, 46-7. PubMed ID: 17623984
[No Abstract] [Full Text] [Related]
3. Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain.
Ghinea N; Lipworth W; Kerridge I
J Eval Clin Pract; 2015 Feb; 21(1):28-33. PubMed ID: 24986307
[TBL] [Abstract][Full Text] [Related]
4. False Claims Act prosecution did not deter off-label drug use in the case of neurontin.
Kesselheim AS; Darby D; Studdert DM; Glynn R; Levin R; Avorn J
Health Aff (Millwood); 2011 Dec; 30(12):2318-27. PubMed ID: 22147859
[TBL] [Abstract][Full Text] [Related]
5. Evolving approaches in the treatment of menopausal symptoms.
Liu JH
Obstet Gynecol; 2006 Jul; 108(1):4-5. PubMed ID: 16816048
[No Abstract] [Full Text] [Related]
6. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
Goodman CW; Brett AS
N Engl J Med; 2017 Aug; 377(5):411-414. PubMed ID: 28767350
[No Abstract] [Full Text] [Related]
7. Confounding factors in off-label drug use.
Greenberg PE; Pike C; Sisitsky T
Health Aff (Millwood); 2012 Feb; 31(2):460; author reply 460. PubMed ID: 22323178
[No Abstract] [Full Text] [Related]
8. Reporting of trials of gabapentin.
Gordh TE; Jensen TS; Kalso E
N Engl J Med; 2010 Apr; 362(17):1641; author reply 1641-2. PubMed ID: 20427815
[No Abstract] [Full Text] [Related]
9. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
Chen DT; Wynia MK; Moloney RM; Alexander GC
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444
[TBL] [Abstract][Full Text] [Related]
10. The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance.
Throckmorton DC; Gottlieb S; Woodcock J
N Engl J Med; 2018 Jul; 379(3):205-207. PubMed ID: 29847203
[No Abstract] [Full Text] [Related]
11. Gabapentin in carpal tunnel patients: A consideration.
Wiwanitkit V
Neurol India; 2009; 57(5):690. PubMed ID: 19934586
[No Abstract] [Full Text] [Related]
12. Gabapentin for uraemic pruritus.
Manenti L; Vaglio A
Nephrol Dial Transplant; 2005 Jun; 20(6):1278-9. PubMed ID: 15840668
[No Abstract] [Full Text] [Related]
13. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.
Chace MJ; Zhang F; Fullerton CA; Huskamp HA; Gilden D; Soumerai SB
J Clin Psychiatry; 2012 Nov; 73(11):1388-94. PubMed ID: 23146199
[TBL] [Abstract][Full Text] [Related]
14. Gabapentin for pain: balancing benefit and harm.
Ebell M; Kripke C
Am Fam Physician; 2006 Feb; 73(3):435. PubMed ID: 16477890
[No Abstract] [Full Text] [Related]
15. Gabapentin for the prophylaxis of episodic migraine in adults.
Fogleman CD
Am Fam Physician; 2014 May; 89(9):714-5. PubMed ID: 24784332
[No Abstract] [Full Text] [Related]
16. Gabapentin as a therapeutic option in uremic pruritus.
Manenti L; Vaglio A; Borgatti PP
Kidney Int; 2008 Feb; 73(4):512; author reply 512-3. PubMed ID: 18235531
[No Abstract] [Full Text] [Related]
17. Nummular headache: another case treated with gabapentin.
Trucco M
J Headache Pain; 2007 Apr; 8(2):137-8. PubMed ID: 17497269
[No Abstract] [Full Text] [Related]
18. How does gabapentin relieve neuropathic pain?
Devor M
Pain; 2009 Sep; 145(1-2):259; author reply 259-61. PubMed ID: 19539428
[No Abstract] [Full Text] [Related]
19. Morphine, gabapentin, or their combination for neuropathic pain.
Baillie JK; Power I
N Engl J Med; 2005 Jun; 352(25):2650-1; author reply 2650-1. PubMed ID: 15972877
[No Abstract] [Full Text] [Related]
20. Taking back your turf: understanding the role of law in medical decision making in opioid management (Part I--overview).
Bolen J
J Opioid Manag; 2005; 1(3):125-30. PubMed ID: 17315415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
